Catherine Van Poznak

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

Dan R. Robinson, Yi-Mi Wu, Pankaj Vats et al. · Nature Genetics · 2013 · 1.2K citations · Full text

Medicine, Genetics, Oncology +14

Bone health in cancer: ESMO Clinical Practice Guidelines

Robert E. Coleman, Peyman Hadji, Jean‐Jacques Body et al. · Annals of Oncology · 2020 · 518 citations · Full text

Medicine, Oncology, Pharmacology +17

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Catherine Van Poznak, Mark R. Somerfield, Robert C. Bast et al. · Journal of Clinical Oncology · 2015 · 394 citations · Full text

Medicine, Clinical Sciences, Oncology +17

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

Catherine Van Poznak, Sarah Temin, Gary C. Yee et al. · Journal of Clinical Oncology · 2011 · 344 citations · Full text

Medicine, Oncology, Bone Metabolism +16

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 338 citations · Full text

Medicine, Oncology, Pharmacology +17